According to GuruFocus Insider Data, these are the largest CFO buys during the past week. They were Flagstar Bancorp Inc., Royal Caribbean Cruises Ltd., The Greenbrier Companies Inc., BioCryst Pharmaceuticals Inc., and Buckeye Technologies Inc.
Flagstar Bancorp Inc. (FBC, Financial): Executive VP and CFO Paul D Borja Bought 150,000 Shares
Executive VP and CFO of Flagstar Bancorp Inc. (FBC) Paul D Borja bought 150,000 shares on 01/30/2009 at an average price of $0.8; the price of the stock has decreased by 2.5% since. Flagstar Bancorp Inc. is the holding company for Flagstar Bank FSB a federally chartered stock savings bank. Through its retail banking centers and e-commerce distribution channels Flagstar attracts deposits from the general public. The institution utilizes these deposits along with other funds garnered from the secondary market to originate or acquire loans on a nationwide basis. Flagstar Bancorp Inc. has a market cap of $66.07 million; its shares were traded at around $0.78 with and P/S ratio of 0.06. Flagstar Bancorp Inc. had an annual average earning growth of 16.6% over the past 10 years.
Flagstar Bancorp Inc. recently reported fiscal results for itsfourth quarter 2008 ended December 31, 2008. The company announced its net lossof $200.3million ($2.40 per diluted share). This is compared to the fourth quarter of the prior year that included a net lossof$30.06million ($0.50 per diluted share).
Arnold Schneider bought 27,150 shares in the quarter that ended on 09/30/2008, which is less than 0.01% of the $2.25 billion portfolio of Schneider Capital Management.
President and CEO, Director Mark T Hammond bought 2,500,000 shares of FBC stock on 01/30/2009 at the average price of $0.8; the price of the stock has decreased by 2.5% since. Director William Pickard bought 31,250 shares of FBC stock on 01/30/2009 at the average price of $0.8; the price of the stock has decreased by 2.5% since. Director Jay J Hansen bought 80,000 shares of FBC stock on 01/30/2009 at the average price of $0.8; the price of the stock has decreased by 2.5% since. Director B Brian Tauber bought 87,500 shares of FBC stock on 01/30/2009 at the average price of $0.8; the price of the stock has decreased by 2.5% since. Chief Accounting Officer Joel Murray bought 6,250 shares of FBC stock on 01/30/2009 at the average price of $0.8; the price of the stock has decreased by 2.5% since. Executive Director, Director Jr Robert O Rondeau bought 75,000 shares of FBC stock on 01/30/2009 at the average price of $0.8; the price of the stock has decreased by 2.5% since. EVP and Chief Legal Officer Matthew Roslin bought 125,000 shares of FBC stock on 01/30/2009 at the average price of $0.8; the price of the stock has decreased by 2.5% since. Executive Director Kirstin A Hammond bought 75,000 shares of FBC stock on 01/30/2009 at the average price of $0.8; the price of the stock has decreased by 2.5% since.
Royal Caribbean Cruises Ltd. (RCL, Financial): EVP, Finance & CFO Brian J Rice Bought 10,000 Shares
EVP, Finance & CFO of Royal Caribbean Cruises Ltd. (RCL) Brian J Rice bought 10,000 shares on 02/03/2009 at an average price of $6.65. Royal Caribbean Cruises Ltd. is a global cruise vacation company that operates Royal Caribbean International Celebrity Cruises and Royal Celebrity Tours. Royal Celebrity Tours operates cruise tour vacations in Alaska utilizing the world's largest glass-domed railcars. Royal Caribbean Cruises Ltd. has a market cap of $2.01 billion; its shares were traded at around $7.34 with a P/E ratio of 3.6 and P/S ratio of 0.33. Royal Caribbean Cruises Ltd. had an annual average earning growth of 6.8% over the past 10 years. GuruFocus rated Royal Caribbean Cruises Ltd. the business predictability rank of 5-star.
Royal Caribbean Cruises Ltd. recently reported fiscal results for its fourth quarter 2008 ended December 31, 2008. The company announced its total revenues of $ 1,456,277 billion, a net incomeof $ $1.5 million ($0.01 per diluted share). This is compared to the fourth quarter the prior year’s total revenues of $ 1,491,095 billion, a net incomeof$70.8million ($0.33 per diluted share). The fourth quarter was an extremely difficult operating environment and we expect even more challenges in 2009," said Richard D. Fain, chairman and chief executive officer. "Nevertheless, I am pleased by our success in reducing costs without compromising the guest experience. Although the WAVE Period has only just started, we are encouraged by what we have seen so far; pricing is still very difficult, but booking patterns have begun to stabilize."
Charles Brandes bought 49,980 shares in the quarter that ended on 09/30/2008, which is less than 0.01% of the $27.58 billion portfolio of Brandes Investment. David Dreman owns 76,300 shares as of 09/30/2008, an increase of 141.46% from the previous quarter. This position accounts for 0.01% of the $10.85 billion portfolio of Dreman Value Management. Bruce Sherman owns 11,095,924 shares as of 09/30/2008, which accounts for 4.61% of the $4.99 billion portfolio of Private Capital Management. Arnold Schneider owns 696,300 shares as of 09/30/2008, which accounts for 0.64% of the $2.25 billion portfolio of Schneider Capital Management. Richard Aster Jr owns 1,287,341 shares as of 09/30/2008, which accounts for 1.02% of the $2.63 billion portfolio of Meridian Fund. John Rogers owns 5,637,865 shares as of 09/30/2008, which accounts for 1.73% of the $6.74 billion portfolio of ARIEL CAPITAL MANAGEMENT LLC.
Pres & CEO,Royal Caribbean Int Adam M Goldstein bought 15,000 shares of RCL stock on 11/21/2008 at the average price of $6.56 and 10,000 shares of RCL stock on 02/03/2009 at the average price of $6.68; the price of the stock has increased by 9.88% since. EVP, Finance & CFO Brian J Rice bought 10,000 shares of RCL stock on 02/03/2009 at the average price of $6.65; the price of the stock has increased by 10.38% since.
The Greenbrier Companies Inc. (GBX, Financial): EVP/Treasurer/CFO Mark J Rittenbaum Bought 5,000 Shares
EVP/Treasurer/CFO of The Greenbrier Companies Inc. (GBX) Mark J Rittenbaum bought 5,000 shares on 02/04/2009 at an average price of $5.62; the price of the stock has increased by 8.01% since. Greenbrier Companies Inc. is a leading supplier of transportation equipment and services to the railroad and related industries. The manufacturing segment produces double-stack intermodal railcars conventional railcars and marine vessels and performs repair and refurbishment activities for both intermodal and conventional railcars. In addition to manufacturing they are engaged in complementary leasing and services activities. The Greenbrier Companies Inc. has a market cap of $94.55 million; its shares were traded at around $6.07 with a P/E ratio of 5.8 and P/S ratio of 0.07. The dividend yield of The Greenbrier Companies Inc. stocks is 2.81%. The Greenbrier Companies Inc. had an annual average earning growth of 3.4% over the past 10 years.
The Greenbrier Companies Inc. recently reported fiscal results for its first quarter 2009 ended November 30, 2008. The company announced its total revenue of $256 million net loss of $3.3 million ($0.20 per diluted share). This is compared to the first quarter last year which included a total revenues of $286 million, a net income of $2.6 million ($0.16 per diluted share). William A. Furman, president and chief executive officer, said, "Our results for the quarter reflect the difficult economic environment in which we currently operate. The less cyclical parts of our business, including Refurbishment & Parts, Leasing & Services, and Marine manufacturing, along with our European operations, have helped to dampen the effect of the downturn. However, the adverse impacts of weak railcar loadings, surplus railcars, and deferments in capital spending by our customers, along with resultant downward pricing pressures, affected all our business during the quarter. Dramatic recent reductions in commodity prices, which are expected to have a positive impact in the long run, adversely affected our Refurbishment & Parts segment during the quarter." John Keeley owns 2,086,700 shares as of 09/30/2008, which accounts for 0.45% of the $9.04 billion portfolio of Keeley Fund Management. T Boone Pickens owns 584,188 shares as of 09/30/2008, which accounts for 0.89% of the $1.29 billion portfolio of BP Capital.
President & CEO, Director William A Furman bought 100,000 shares of GBX stock on 11/17/2008 at the average price of $6.88, 49,600 shares of GBX stock on 11/24/2008 at the average price of $6, 2,100 shares of GBX stock on 11/26/2008 at the average price of $6.3, 40,300 shares of GBX stock on 01/15/2009 at the average price of $5.31, 9,700 shares of GBX stock on 01/16/2009 at the average price of $6, and 40,000 shares of GBX stock on 01/20/2009 at the average price of $5.48; the price of the stock has increased by 10.77% since. Director Donald A Washburn bought 2,000 shares of GBX stock on 11/13/2008 at the average price of $6.47, 2,000 shares of GBX stock on 11/20/2008 at the average price of $5.27, 8,000 shares of GBX stock on 01/16/2009 at the average price of $5.48, and 2,000 shares of GBX stock on 01/23/2009 at the average price of $5.71; the price of the stock has increased by 6.3% since. Director C Bruce Ward bought 10,000 shares of GBX stock on 12/09/2008 at the average price of $5.5; the price of the stock has increased by 10.36% since. Emeritus Director Victor G Atiyeh bought 4,000 shares of GBX stock on 12/03/2008 at the average price of $6.18; the price of the stock has decreased by 1.78% since. Director Benjamin R Whiteley bought 5,000 shares of GBX stock on 11/19/2008 at the average price of $6.6, and 2,500 shares of GBX stock on 11/21/2008 at the average price of $4.86; the price of the stock has increased by 24.9% since. Director A Daniel Oneal bought 3,000 shares of GBX stock on 11/18/2008 at the average price of $7.38; the price of the stock has decreased by 17.75% since.
BioCryst Pharmaceuticals Inc. (BCRX, Financial): SR VP & CFO Stuart Grant Bought 3,000 Shares
SR VP & CFO of BioCryst Pharmaceuticals Inc. (BCRX) Stuart Grant bought 3,000 shares on 01/30/2009 at an average price of $1.62; the price of the stock has increased by 11.11% since. BioCryst Pharmaceuticals Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer cardiovascular diseases autoimmune diseases and viral infections. The company is advancing multiple internal programs toward potential commercialization including Fodosine in oncology BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life threatening influenza. BioCryst is collaborating with Mundipharma for the development and commercialization of Forodesine HCl in markets across Europe Asia Australia and certain neighboring countries. BioCryst Pharmaceuticals Inc. has a market cap of $70.78 million; its shares were traded at around $1.8 with and P/S ratio of 0.99. BioCryst Pharmaceuticals Inc. had an annual average earning growth of 8.4% over the past 5 years.
BioCryst Pharmaceuticals Inc. recently reported fiscal results for its fourth quarter 2008 ended December 31, 2008. The company announced its net income of $10.1 million ($0.26 per diluted share). This is compared to the fourth quarter last year which included a net loss of $2.3 million ($0.06 per diluted share). We made significant headway in our clinical programs in 2008 and have a cash position that will enable us to fund our clinical programs well into 2010," stated Jon Stonehouse, President and Chief Executive Officer of BioCryst. "We were pleased to report positive data, from both our internal and partnered peramivir programs, and look forward to evaluating the data from our ongoing peramivir trials. In 2009, we hope to report top-line data from our Phase 2 trial of peramivir in outpatient influenza and subsequently initiate a Phase 3 program in this indication, and will continue to progress our PNP programs."
President & CEO, Director Jon P Stonehouse bought 83,000 shares of BCRX stock from 11/03/2008 through 01/30/2009; the price of the stock has increased by 11.11% since. SR VP - CMO William P Sheridan bought 3,000 shares of BCRX stock on 01/30/2009 at the average price of $1.62; the price of the stock has increased by 11.11% since. 10% Owner Bros. Capital (gp), Llc Baker bought 432 shares of BCRX stock on 11/24/2008 at the average price of $1; the price of the stock has increased by 80% since. 10% Owner Brothers Life Sciences C Baker bought 310,918 shares of BCRX stock on 11/24/2008 at the average price of $1; the price of the stock has increased by 80% since. 10% Owner Biotech Capital (gp), Ll Baker bought 98,372 shares of BCRX stock on 11/24/2008 at the average price of $1; the price of the stock has increased by 80% since. 10% Owner Capital (gp), Llc 14159 bought 8,479 shares of BCRX stock on 11/24/2008 at the average price of $1; the price of the stock has increased by 80% since. 10% Owner / Tisch Capital (gp), Ll Baker bought 2,077 shares of BCRX stock on 11/24/2008 at the average price of $1; the price of the stock has increased by 80% since.
Buckeye Technologies Inc. (BKI, Financial): Sr VP, CFO Steven G Dean Bought 2,192 Shares
Sr VP, CFO of Buckeye Technologies Inc. (BKI) Steven G Dean bought 2,192 shares on 02/02/2009 at an average price of $3.19. Buckeye Technologies Inc. is a leading manufacturer and worldwide marketer of value-added cellulose-based specialty products. The company utilizes its expertise in polymer chemistry and its state-of-the-art manufacturing facilities to develop and produce innovative and proprietary products for its customers. The company sells its products to a wide array of technically demanding niche markets in which its proprietary products and commitment to customer technical service give it a competitive advantage. Buckeye Technologies Inc. has a market cap of $110.14 million; its shares were traded at around $3.3 with a P/E ratio of 3 and P/S ratio of 0.13. Buckeye Technologies Inc. had an annual average earning growth of 23.8% over the past 5 years.
Buckeye Technologies Inc. recently reported fiscal results for October-December quarter 2008. The company announced net income of $0.07 per diluted share. This is compared to the NUMBER quarter last year which included a net income of $0.35 per diluted share. Chairman and Chief Executive Officer John B. Crowe said, "This has been a challenging quarter for Buckeye, as the global economic recession has reduced demand for some of our products. While demand for most of our high-end specialty wood products remains solid, demand for our specialty cotton fibers has weakened significantly. Sales of our airlaid nonwovens products were also down primarily due to customer inventory reductions and normal seasonal weakness in Europe in December. As we previously announced, we took market downtime at our Foley, Memphis and Americana plants during the quarter to match production to shipment demand. In addition to a company-wide focus on reducing costs and maintaining tight control over our working capital, we have reduced our planned capital spending for this fiscal year from $64 million to $40 million in order to accelerate debt reduction efforts. We have established a goal of paying down our debt from the current level of $391 million to $350 million by December 2009 in order to ensure that we have sufficient borrowing capacity on our $200 million revolving credit facility to pay off the $110 million in bonds which mature in October 2010 without going to the credit markets for new financing. Buckeye was well in compliance with all of its debt covenants and had $114 million in available borrowing capacity plus $8.5 million in cash on its balance sheet at the end of December."
NWQ Managers owns 1,832,207 shares as of 09/30/2008, which accounts for 0.07% of the $20.62 billion portfolio of NWQ Investment Management Co.
Chairman, CEO, Director John B Crowe bought 21473 of BKI stock from 11/30/2008 through 01/29/2009; the price of stack has increased by 25% since. Director R Howard Cannon bought 52,100 shares of BKI stock from 01/29/2009 through 02/05/2009; the price of the stock has increased by 14.98% since. Sr VP, Prod. & Mkt Development Paul N Horne bought 5,000 shares of BKI stock on 01/29/2009 at the average price of $2.6; the price of the stock has increased by 26.92% since. Director Kathy Buckman Davis bought 2,000 shares of BKI stock on 12/09/2008 at the average price of $3.1 and 3,000 shares of BKI stock on 12/11/2008 at the average price of $3.6; the price of the stock has decreased by 8.33% since. Director R Howard Cannon bought 5,200 shares of BKI stock on 12/09/2008 at the average price of $3.09; the price of the stock has increased by 6.8% since. Sr VP, Prod & Mkt Development Paul N Horne bought 2,045 shares of BKI stock on 12/05/2008 at the average price of $3.5; the price of the stock has decreased by 5.71% since. Sr VP Prod & Mkt Development Paul N Horne bought 2,000 shares of BKI stock on 11/21/2008 at the average price of $3.23; the price of the stock has increased by 2.17% since. Sr VP, MFG & Sustainability Charles S Aiken bought 8,136 shares of BKI stock on 11/25/2008 at the average price of $3.95; the price of the stock has decreased by 16.46% since.
Flagstar Bancorp Inc. (FBC, Financial): Executive VP and CFO Paul D Borja Bought 150,000 Shares
Executive VP and CFO of Flagstar Bancorp Inc. (FBC) Paul D Borja bought 150,000 shares on 01/30/2009 at an average price of $0.8; the price of the stock has decreased by 2.5% since. Flagstar Bancorp Inc. is the holding company for Flagstar Bank FSB a federally chartered stock savings bank. Through its retail banking centers and e-commerce distribution channels Flagstar attracts deposits from the general public. The institution utilizes these deposits along with other funds garnered from the secondary market to originate or acquire loans on a nationwide basis. Flagstar Bancorp Inc. has a market cap of $66.07 million; its shares were traded at around $0.78 with and P/S ratio of 0.06. Flagstar Bancorp Inc. had an annual average earning growth of 16.6% over the past 10 years.
Flagstar Bancorp Inc. recently reported fiscal results for itsfourth quarter 2008 ended December 31, 2008. The company announced its net lossof $200.3million ($2.40 per diluted share). This is compared to the fourth quarter of the prior year that included a net lossof$30.06million ($0.50 per diluted share).
Arnold Schneider bought 27,150 shares in the quarter that ended on 09/30/2008, which is less than 0.01% of the $2.25 billion portfolio of Schneider Capital Management.
President and CEO, Director Mark T Hammond bought 2,500,000 shares of FBC stock on 01/30/2009 at the average price of $0.8; the price of the stock has decreased by 2.5% since. Director William Pickard bought 31,250 shares of FBC stock on 01/30/2009 at the average price of $0.8; the price of the stock has decreased by 2.5% since. Director Jay J Hansen bought 80,000 shares of FBC stock on 01/30/2009 at the average price of $0.8; the price of the stock has decreased by 2.5% since. Director B Brian Tauber bought 87,500 shares of FBC stock on 01/30/2009 at the average price of $0.8; the price of the stock has decreased by 2.5% since. Chief Accounting Officer Joel Murray bought 6,250 shares of FBC stock on 01/30/2009 at the average price of $0.8; the price of the stock has decreased by 2.5% since. Executive Director, Director Jr Robert O Rondeau bought 75,000 shares of FBC stock on 01/30/2009 at the average price of $0.8; the price of the stock has decreased by 2.5% since. EVP and Chief Legal Officer Matthew Roslin bought 125,000 shares of FBC stock on 01/30/2009 at the average price of $0.8; the price of the stock has decreased by 2.5% since. Executive Director Kirstin A Hammond bought 75,000 shares of FBC stock on 01/30/2009 at the average price of $0.8; the price of the stock has decreased by 2.5% since.
Royal Caribbean Cruises Ltd. (RCL, Financial): EVP, Finance & CFO Brian J Rice Bought 10,000 Shares
EVP, Finance & CFO of Royal Caribbean Cruises Ltd. (RCL) Brian J Rice bought 10,000 shares on 02/03/2009 at an average price of $6.65. Royal Caribbean Cruises Ltd. is a global cruise vacation company that operates Royal Caribbean International Celebrity Cruises and Royal Celebrity Tours. Royal Celebrity Tours operates cruise tour vacations in Alaska utilizing the world's largest glass-domed railcars. Royal Caribbean Cruises Ltd. has a market cap of $2.01 billion; its shares were traded at around $7.34 with a P/E ratio of 3.6 and P/S ratio of 0.33. Royal Caribbean Cruises Ltd. had an annual average earning growth of 6.8% over the past 10 years. GuruFocus rated Royal Caribbean Cruises Ltd. the business predictability rank of 5-star.
Royal Caribbean Cruises Ltd. recently reported fiscal results for its fourth quarter 2008 ended December 31, 2008. The company announced its total revenues of $ 1,456,277 billion, a net incomeof $ $1.5 million ($0.01 per diluted share). This is compared to the fourth quarter the prior year’s total revenues of $ 1,491,095 billion, a net incomeof$70.8million ($0.33 per diluted share). The fourth quarter was an extremely difficult operating environment and we expect even more challenges in 2009," said Richard D. Fain, chairman and chief executive officer. "Nevertheless, I am pleased by our success in reducing costs without compromising the guest experience. Although the WAVE Period has only just started, we are encouraged by what we have seen so far; pricing is still very difficult, but booking patterns have begun to stabilize."
Charles Brandes bought 49,980 shares in the quarter that ended on 09/30/2008, which is less than 0.01% of the $27.58 billion portfolio of Brandes Investment. David Dreman owns 76,300 shares as of 09/30/2008, an increase of 141.46% from the previous quarter. This position accounts for 0.01% of the $10.85 billion portfolio of Dreman Value Management. Bruce Sherman owns 11,095,924 shares as of 09/30/2008, which accounts for 4.61% of the $4.99 billion portfolio of Private Capital Management. Arnold Schneider owns 696,300 shares as of 09/30/2008, which accounts for 0.64% of the $2.25 billion portfolio of Schneider Capital Management. Richard Aster Jr owns 1,287,341 shares as of 09/30/2008, which accounts for 1.02% of the $2.63 billion portfolio of Meridian Fund. John Rogers owns 5,637,865 shares as of 09/30/2008, which accounts for 1.73% of the $6.74 billion portfolio of ARIEL CAPITAL MANAGEMENT LLC.
Pres & CEO,Royal Caribbean Int Adam M Goldstein bought 15,000 shares of RCL stock on 11/21/2008 at the average price of $6.56 and 10,000 shares of RCL stock on 02/03/2009 at the average price of $6.68; the price of the stock has increased by 9.88% since. EVP, Finance & CFO Brian J Rice bought 10,000 shares of RCL stock on 02/03/2009 at the average price of $6.65; the price of the stock has increased by 10.38% since.
The Greenbrier Companies Inc. (GBX, Financial): EVP/Treasurer/CFO Mark J Rittenbaum Bought 5,000 Shares
EVP/Treasurer/CFO of The Greenbrier Companies Inc. (GBX) Mark J Rittenbaum bought 5,000 shares on 02/04/2009 at an average price of $5.62; the price of the stock has increased by 8.01% since. Greenbrier Companies Inc. is a leading supplier of transportation equipment and services to the railroad and related industries. The manufacturing segment produces double-stack intermodal railcars conventional railcars and marine vessels and performs repair and refurbishment activities for both intermodal and conventional railcars. In addition to manufacturing they are engaged in complementary leasing and services activities. The Greenbrier Companies Inc. has a market cap of $94.55 million; its shares were traded at around $6.07 with a P/E ratio of 5.8 and P/S ratio of 0.07. The dividend yield of The Greenbrier Companies Inc. stocks is 2.81%. The Greenbrier Companies Inc. had an annual average earning growth of 3.4% over the past 10 years.
The Greenbrier Companies Inc. recently reported fiscal results for its first quarter 2009 ended November 30, 2008. The company announced its total revenue of $256 million net loss of $3.3 million ($0.20 per diluted share). This is compared to the first quarter last year which included a total revenues of $286 million, a net income of $2.6 million ($0.16 per diluted share). William A. Furman, president and chief executive officer, said, "Our results for the quarter reflect the difficult economic environment in which we currently operate. The less cyclical parts of our business, including Refurbishment & Parts, Leasing & Services, and Marine manufacturing, along with our European operations, have helped to dampen the effect of the downturn. However, the adverse impacts of weak railcar loadings, surplus railcars, and deferments in capital spending by our customers, along with resultant downward pricing pressures, affected all our business during the quarter. Dramatic recent reductions in commodity prices, which are expected to have a positive impact in the long run, adversely affected our Refurbishment & Parts segment during the quarter." John Keeley owns 2,086,700 shares as of 09/30/2008, which accounts for 0.45% of the $9.04 billion portfolio of Keeley Fund Management. T Boone Pickens owns 584,188 shares as of 09/30/2008, which accounts for 0.89% of the $1.29 billion portfolio of BP Capital.
President & CEO, Director William A Furman bought 100,000 shares of GBX stock on 11/17/2008 at the average price of $6.88, 49,600 shares of GBX stock on 11/24/2008 at the average price of $6, 2,100 shares of GBX stock on 11/26/2008 at the average price of $6.3, 40,300 shares of GBX stock on 01/15/2009 at the average price of $5.31, 9,700 shares of GBX stock on 01/16/2009 at the average price of $6, and 40,000 shares of GBX stock on 01/20/2009 at the average price of $5.48; the price of the stock has increased by 10.77% since. Director Donald A Washburn bought 2,000 shares of GBX stock on 11/13/2008 at the average price of $6.47, 2,000 shares of GBX stock on 11/20/2008 at the average price of $5.27, 8,000 shares of GBX stock on 01/16/2009 at the average price of $5.48, and 2,000 shares of GBX stock on 01/23/2009 at the average price of $5.71; the price of the stock has increased by 6.3% since. Director C Bruce Ward bought 10,000 shares of GBX stock on 12/09/2008 at the average price of $5.5; the price of the stock has increased by 10.36% since. Emeritus Director Victor G Atiyeh bought 4,000 shares of GBX stock on 12/03/2008 at the average price of $6.18; the price of the stock has decreased by 1.78% since. Director Benjamin R Whiteley bought 5,000 shares of GBX stock on 11/19/2008 at the average price of $6.6, and 2,500 shares of GBX stock on 11/21/2008 at the average price of $4.86; the price of the stock has increased by 24.9% since. Director A Daniel Oneal bought 3,000 shares of GBX stock on 11/18/2008 at the average price of $7.38; the price of the stock has decreased by 17.75% since.
BioCryst Pharmaceuticals Inc. (BCRX, Financial): SR VP & CFO Stuart Grant Bought 3,000 Shares
SR VP & CFO of BioCryst Pharmaceuticals Inc. (BCRX) Stuart Grant bought 3,000 shares on 01/30/2009 at an average price of $1.62; the price of the stock has increased by 11.11% since. BioCryst Pharmaceuticals Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer cardiovascular diseases autoimmune diseases and viral infections. The company is advancing multiple internal programs toward potential commercialization including Fodosine in oncology BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life threatening influenza. BioCryst is collaborating with Mundipharma for the development and commercialization of Forodesine HCl in markets across Europe Asia Australia and certain neighboring countries. BioCryst Pharmaceuticals Inc. has a market cap of $70.78 million; its shares were traded at around $1.8 with and P/S ratio of 0.99. BioCryst Pharmaceuticals Inc. had an annual average earning growth of 8.4% over the past 5 years.
BioCryst Pharmaceuticals Inc. recently reported fiscal results for its fourth quarter 2008 ended December 31, 2008. The company announced its net income of $10.1 million ($0.26 per diluted share). This is compared to the fourth quarter last year which included a net loss of $2.3 million ($0.06 per diluted share). We made significant headway in our clinical programs in 2008 and have a cash position that will enable us to fund our clinical programs well into 2010," stated Jon Stonehouse, President and Chief Executive Officer of BioCryst. "We were pleased to report positive data, from both our internal and partnered peramivir programs, and look forward to evaluating the data from our ongoing peramivir trials. In 2009, we hope to report top-line data from our Phase 2 trial of peramivir in outpatient influenza and subsequently initiate a Phase 3 program in this indication, and will continue to progress our PNP programs."
President & CEO, Director Jon P Stonehouse bought 83,000 shares of BCRX stock from 11/03/2008 through 01/30/2009; the price of the stock has increased by 11.11% since. SR VP - CMO William P Sheridan bought 3,000 shares of BCRX stock on 01/30/2009 at the average price of $1.62; the price of the stock has increased by 11.11% since. 10% Owner Bros. Capital (gp), Llc Baker bought 432 shares of BCRX stock on 11/24/2008 at the average price of $1; the price of the stock has increased by 80% since. 10% Owner Brothers Life Sciences C Baker bought 310,918 shares of BCRX stock on 11/24/2008 at the average price of $1; the price of the stock has increased by 80% since. 10% Owner Biotech Capital (gp), Ll Baker bought 98,372 shares of BCRX stock on 11/24/2008 at the average price of $1; the price of the stock has increased by 80% since. 10% Owner Capital (gp), Llc 14159 bought 8,479 shares of BCRX stock on 11/24/2008 at the average price of $1; the price of the stock has increased by 80% since. 10% Owner / Tisch Capital (gp), Ll Baker bought 2,077 shares of BCRX stock on 11/24/2008 at the average price of $1; the price of the stock has increased by 80% since.
Buckeye Technologies Inc. (BKI, Financial): Sr VP, CFO Steven G Dean Bought 2,192 Shares
Sr VP, CFO of Buckeye Technologies Inc. (BKI) Steven G Dean bought 2,192 shares on 02/02/2009 at an average price of $3.19. Buckeye Technologies Inc. is a leading manufacturer and worldwide marketer of value-added cellulose-based specialty products. The company utilizes its expertise in polymer chemistry and its state-of-the-art manufacturing facilities to develop and produce innovative and proprietary products for its customers. The company sells its products to a wide array of technically demanding niche markets in which its proprietary products and commitment to customer technical service give it a competitive advantage. Buckeye Technologies Inc. has a market cap of $110.14 million; its shares were traded at around $3.3 with a P/E ratio of 3 and P/S ratio of 0.13. Buckeye Technologies Inc. had an annual average earning growth of 23.8% over the past 5 years.
Buckeye Technologies Inc. recently reported fiscal results for October-December quarter 2008. The company announced net income of $0.07 per diluted share. This is compared to the NUMBER quarter last year which included a net income of $0.35 per diluted share. Chairman and Chief Executive Officer John B. Crowe said, "This has been a challenging quarter for Buckeye, as the global economic recession has reduced demand for some of our products. While demand for most of our high-end specialty wood products remains solid, demand for our specialty cotton fibers has weakened significantly. Sales of our airlaid nonwovens products were also down primarily due to customer inventory reductions and normal seasonal weakness in Europe in December. As we previously announced, we took market downtime at our Foley, Memphis and Americana plants during the quarter to match production to shipment demand. In addition to a company-wide focus on reducing costs and maintaining tight control over our working capital, we have reduced our planned capital spending for this fiscal year from $64 million to $40 million in order to accelerate debt reduction efforts. We have established a goal of paying down our debt from the current level of $391 million to $350 million by December 2009 in order to ensure that we have sufficient borrowing capacity on our $200 million revolving credit facility to pay off the $110 million in bonds which mature in October 2010 without going to the credit markets for new financing. Buckeye was well in compliance with all of its debt covenants and had $114 million in available borrowing capacity plus $8.5 million in cash on its balance sheet at the end of December."
NWQ Managers owns 1,832,207 shares as of 09/30/2008, which accounts for 0.07% of the $20.62 billion portfolio of NWQ Investment Management Co.
Chairman, CEO, Director John B Crowe bought 21473 of BKI stock from 11/30/2008 through 01/29/2009; the price of stack has increased by 25% since. Director R Howard Cannon bought 52,100 shares of BKI stock from 01/29/2009 through 02/05/2009; the price of the stock has increased by 14.98% since. Sr VP, Prod. & Mkt Development Paul N Horne bought 5,000 shares of BKI stock on 01/29/2009 at the average price of $2.6; the price of the stock has increased by 26.92% since. Director Kathy Buckman Davis bought 2,000 shares of BKI stock on 12/09/2008 at the average price of $3.1 and 3,000 shares of BKI stock on 12/11/2008 at the average price of $3.6; the price of the stock has decreased by 8.33% since. Director R Howard Cannon bought 5,200 shares of BKI stock on 12/09/2008 at the average price of $3.09; the price of the stock has increased by 6.8% since. Sr VP, Prod & Mkt Development Paul N Horne bought 2,045 shares of BKI stock on 12/05/2008 at the average price of $3.5; the price of the stock has decreased by 5.71% since. Sr VP Prod & Mkt Development Paul N Horne bought 2,000 shares of BKI stock on 11/21/2008 at the average price of $3.23; the price of the stock has increased by 2.17% since. Sr VP, MFG & Sustainability Charles S Aiken bought 8,136 shares of BKI stock on 11/25/2008 at the average price of $3.95; the price of the stock has decreased by 16.46% since.
